© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Acutase didn’t fall from the sky one day to solve a sudden problem in cell culture. The long road to this product draws lines back to decades when labs relied almost exclusively on trypsin for detaching cells from plastic. Trypsin, coming from porcine or bovine sources, faced practical and safety complaints—animal products bring along contamination risks and complicated regulatory landscapes. Scientists kept running into enzyme-induced cellular damage, receptor cleavage, and unpredictable detachment. By the late 20th century, research demanded something gentler and more predictable: a detachment solution that preserved vital cell surface markers. Acutase emerged from that context, a cocktail of proteolytic and collagenolytic enzymes redesigned for cell culture’s modern demands. Teams built its formula to not just release adherent cells, but keep their membranes and signaling machinery intact, opening up new experimental possibilities for immunology, stem cell biology, and regenerative medicine.
At its core, Acutase serves as a non-mammalian enzymatic blend for detaching cells from plastic or dissociating tissues into single-cell suspensions. It stands apart from traditional animal-derived enzymes by using recombinant technology and including both proteases and collagenases. This means researchers can count on lower variability, improved batch-to-batch consistency, and fewer concerns about introducing animal pathogens. For a long time, cell culture work meant making a trade-off between detachment efficiency and the cost to cell health. Acutase upends that calculus. It works at room temperature, in a neutral pH environment, trimming away at intercellular adhesions without hacking away at surface antigens or receptors. Researchers have found its approach reduces the stress on sensitive cell lines and primary cells, supporting downstream applications that depend on cells staying in peak condition.
Acutase is clear, with a light-yellow color. It flows with a viscosity close to water, so pipetting feels no different than transferring usual lab fluids. The enzyme solution carries a slightly basic pH, designed to match the physiological range that most mammalian cells love. Stability has become a big selling point; on ice, Acutase holds up for months without losing activity, which can’t be said for all enzymatic blends. It won’t foam up under agitation. Laboratories around the world appreciate being able to avoid refrigeration except for long storage, as Acutase keeps its punch at room temperature when needed for short-term benchwork.
Every Acutase vial or bottle displays enzyme concentration, storage guidance, and expiry dates. Detailed labeling spells out the absence of animal-derived ingredients, which smooths over compliance hurdles when researchers submit protocols for clinical or translational work. Each lot comes with documentation for sterility and shelf life. Unlike older generation products, transparency about ingredient sources and activity range allows scientists to plan protocols without nasty surprises mid-experiment. Quality control in production keeps units consistent, reducing those all-too-familiar headaches with cell attachment or viability that used to come with less reliable detachment agents.
Getting Acutase ready isn’t rocket science. It comes sterile and pre-diluted for direct use, eliminating the risk of contamination that used to haunt trypsin preparation. Researchers usually bring the stock to room temperature and pipette it directly onto adherent cell layers, bathing the cells and covering with enough volume to keep everything submerged. After a few minutes, gentle tapping or brief agitation loosens cells from the vessel. Those handling larger tissue chunks may pre-rinse the tissue, then incubate in Acutase with periodic pipetting to encourage dissociation. As soon as cells detach, transferring the suspension to growth media halts enzymatic activity and protects cell integrity. Lab teams like the time they save without mixing, titrating, or supplementing, which adds up over long weeks of repetitive culture work.
Acutase owes its effectiveness to a precise balance of active proteases and collagenases. The mix targets peptide bonds in proteins holding cells engaged with their neighbors or vessel substrate, but skips over other extracellular matrix components, so cells maintain more of their natural receptors and signaling domains. The blend’s pH and ionic composition mimic the cellular environment, keeping reactions local and controlled. For applications that demand even more gentleness—such as single-cell transcriptome sequencing—researchers dilute Acutase or cut incubation times further. In rare cases, lab teams spike the product with DNAse or other enzymes to break down extracellular DNA once cells have died or lysed, preventing clumping. Acutase does not react with common plasticware or media additives. Scientists have been known to tweak other culture parameters, like calcium or magnesium presence, to match specific cell line quirks, but the core chemistry remains user-friendly and surprisingly forgiving.
Acutase sometimes goes by its historical predecessors, with researchers referencing it alongside detachment solutions like Accutase, Gentle Cell Dissociation Reagent, or “animal-free trypsin alternative.” Different suppliers package similar blends under house brands, leading to regional nicknames and spellings, but the essence stays true. Scientists have grown fond of the shift in language from “trypsinization” to “Acutase treatment,” a reflection of the measure of trust built up around these animal-free blends.
Laboratories using Acutase rely on standard sterile technique, as with any cell culture work. The product poses low hazard risks, with few reports of skin or eye irritation, though gloves and eye protection remain routine. Most documentation flags the product as non-toxic at working concentrations. Disposal follows the usual rules for non-infectious biological waste. Universal precautions, like bench disinfection and avoidance of splashing, keep researchers safe. Some labs perform routine post-detachment washes to remove any residual enzyme, especially when preparing cells for sensitive assays, just to ensure long-term culture health. Equipment doesn’t need the harsh post-trypsin cleaning regimens of the past, cutting down on plastic and glassware replacement. Safety data sheets tell the story: straightforward, no arcane warnings or rare allergic reactions, making Acutase fit smoothly into everyday lab routines without extra paperwork.
Acutase revolutionized more than just cell passaging. Lab teams use it in embryonic stem cell culture to maintain delicate colonies, neural stem cell preparation where receptor sensitivity matters, and in preparing primary cultures from organs like lung, skin, or pancreas. Clinical labs run Acutase-based workflows to prep human cell products for infusion into patients, sidestepping animal component concerns. Flow cytometry, single-cell RNA sequencing, and advanced imaging demand cells carry intact surface markers, which Acutase supports better than trypsin or EDTA. Biotech startups use the product to grow organoids, perform high-throughput drug screening, or engineer tissues. Tissue engineering companies trust animal-free detachment agents like Acutase when moving toward Good Manufacturing Practice production. The shift has opened countless research avenues previously closed off due to enzyme harshness or contamination risks.
Acutase didn’t appear out of thin air. Teams working in protein chemistry and cell biology collaborated to refine enzyme mixtures, screening activity on dozens of sensitive cell lines. Over years, researchers tweaked the blend for minimal proteolysis of cell surface antigens and tested for performance across human and animal cells. Ongoing R&D sharpens product consistency, shelf stability, and performance in new cell and tissue types. The shift to animal-free production owes much to regulatory changes in clinical manufacturing, but scientific curiosity drove the envelope. Scientists keep searching for even milder agents, including enzyme-free chemical dissociation methods, building on the foundation constructed by Acutase and its cousins. The quest for reproducibility, cell viability, and safety assures attention remains high in this field, driving future improvements.
No cell detachment agent comes free of toxicity concerns, though Acutase’s profile remains among the gentlest. Research in peer-reviewed journals finds that, compared to trypsin and harsher proteases, Acutase leaves cell viability uncompromised, preserves more membrane proteins, and doesn't introduce significant cellular stress at working concentrations. Extended incubations or improper handling, like leaving cells in Acutase for prolonged periods, can reduce viability—but that risk already plagues all enzymatic detachment methods. Toxicological data so far signals peace of mind for routine lab use, with no strong evidence for acute or cumulative hazard under standard practice. For downstream animal or human use, regulators still demand washout and validation experiments, but the move away from animal enzymes remains a win for reproducibility and ethical compliance.
The story of Acutase speaks to where life sciences push next. The push for xeno-free, defined cell culture products won’t slow down. As single-cell sequencing and regenerative medicine scale up, researchers press for even more refined dissociation agents—ones that chip away at the last bits of cellular stress or speed up tissue disaggregation in large-scale production. Future prospecting wraps around enzyme-free chemical solutions, automated workflows that monitor cell status in real time, and synthetic biology approaches crafting enzymes with customized activity profiles. Academic and industrial pipelines test whether modified Acutase blends could play a part in organ printing, disease modeling, or cellular therapies just entering the clinic. Every tweak and iteration narrows the gap between bench science and clinical translation, where the safety, reliability, and gentle touch of a product like Acutase can make the difference not only for experiments, but ultimately, for patients waiting on the world's next big breakthrough in cell-based medicine.
Acutase isn’t a word folks stumble across unless they work in the world of cell biology. Back in the day, I saw a lot of researchers sticking with trypsin every time they wanted to detach cells from a culture plate. Some stuck with that enzyme out of habit, even though the results sometimes looked rough. That changed when their cultures needed a gentler touch. Acutase entered the conversation.
This enzymatic solution helps gently move cells off surfaces without chewing up the proteins on their membrane. It matters a lot because surface proteins help cells communicate and stick together. Destroying those with harsher chemicals can tilt experiments in the wrong direction, especially if the goal is sorting live cells, counting them, or starting a fresh batch for another experiment.
Trypsin has earned its stripes over decades, but its aggressive nature causes headaches—damaging surface markers important for tasks like flow cytometry. Watching data go sideways because of damaged proteins wastes time and money. Acutase gently detaches cells, helps preserve those important proteins, and keeps cells viable.
Working with neural progenitors or stem cells turns into a gamble with something harsh like trypsin. These cells barely tolerate stress. Acutase makes a big difference, keeping more alive and in good shape for downstream work. In my experience, switching to Acutase improved results for teams working on delicate cells—recovering more viable cells at the end of the process.
A researcher rinses off the growth media, adds cold or room temperature Acutase, and lets it sit based on the cell line’s stickiness. After a few minutes, cells round up and detach without much coaxing. For fragile cell types or sensitive analysis, gentle pipetting removes them without breaking a sweat.
Unlike trypsin, there’s less risk of over-digesting. That means surface markers and other proteins stay mostly intact. This change reduces variability and means fewer troubleshooting sessions. Less damage during detachment leads to healthier cultures, and for anyone prepping cells for sorting, transplant, or sensitive assays, that’s essential.
Messy detachment can mess up experiments focused on surface antigens. I’ve seen labs spend hours troubleshooting antibody staining panels, not realizing the enzyme in the harvesting step was the culprit. Once they swapped to Acutase, their cell markers stayed put, and antibody panels read correctly. Teams saw stronger, more reliable data without redesigning everything upstream.
Not everything comes for free—Acutase typically costs more than basic enzymes. Academic labs with tight budgets sometimes hesitate. But for experiments where cell quality decides if a study works or crashes, skimping on enzyme quality makes little sense. Core facilities often keep Acutase on hand, giving more labs access without driving up costs across entire grant budgets.
Cells don’t get a vote, but giving them a gentler way off the plate leads to better science. Keeping membrane proteins happy helps data make sense. As more experiments focus on live cell function or downstream omics, Acutase’s role isn’t going anywhere. Smart lab management weighs the upfront cost against the price of chasing unreliable data.
A scientist spends hours carefully growing cells, hoping nothing goes wrong between incubator checks. Trypsin shows up as a long-running favorite for detaching cells, yet it plays rough. I remember watching cell lines I worked on get sluggish after repeated trypsin passages, and that’s far from rare. Trypsin bites off surface proteins from cells along with detaching them. Cells lose key markers and can behave unpredictably after several rounds. People who depend on consistent results—immunologists, stem cell folk, or folks running cell-based assays—pay a price each time surface markers drift or cells grow tired of the treatment.
Acutase isn’t just another enzyme mix. The blend works slower and milder. Researchers looking to harvest fragile cell types, like stem cells or primary neuronal cells, found Acutase preserves more than just viability—it keeps the identity intact. The difference jumps out under the microscope: colonies stay tightly packed, cell membranes suffer less scrubbing, and the phenotypic markers stick around longer. That matters during fluorescence-activated cell sorting (FACS) or downstream single-cell sequencing, which rely on those surface proteins for correct identification or sorting. Unlike trypsin, Acutase helps keep fingerprints on the cells, rather than scrubbing them off with every passage.
Trypsin comes from porcine or bovine pancreas—so animal proteins end up in the dish. People who spend enough time at the tissue culture hood know about headaches like mycoplasma outbreaks and the risk of zoonotic microbial contaminants. Using an animal-free reagent like Acutase gives peace of mind. Stem cell research, clinical cell therapy, and facilities bound by good manufacturing practice (GMP) all push toward animal component-free processes. Reducing dependency on animal-derived enzymes feels more secure for people who manage high-stakes research or regulatory materials.
Trypsin needs careful handling. Miss the timer, and the damage grows fast. Acutase gives a broader working window. Even if you run to grab a new pipette tip or send an unexpected text, Acutase usually holds up without hammering cell viability. For high-throughput labs or when training newcomers, there’s less stress over precise timing. The reduction in cell clumping and improved recovery rates, especially for sensitive lines, buys back time otherwise wasted troubleshooting odd culture behavior or reestablishing lines.
People often stick with trypsin by habit or because budgets are tight. Yet, recurring costs from cell loss, failed splits, or unreliable downstream data eat away anything saved on cheaper enzyme. Acutase lets researchers standardize splits longer, cut down batch variability, and reduce bad surprise outcomes after passaging. Colleagues in my own network mention smoother transitions to single-cell work and better yields on difficult lines as top highlights.
People won’t abandon trypsin overnight, but the gradual shift to Acutase says a lot. Science moves forward by dropping old habits when better tools show up. Investing in solutions that keep cells healthy and research reproducible supports not just good science, but better health outcomes down the line. The switch to Acutase echoes this—sometimes, the gentle approach outlasts the rough one.
Acutase steps in where trypsin often leaves off. It’s an enzyme blend designed to gently detach cells from a culture dish. Researchers reach for it because there’s less damage and fewer worries about chopping up cell surface proteins. Some believe it's a natural fit for delicate cell types, especially stem cells and other sensitive lines.
Anyone who’s worked with stem cells knows how touchy they get during passaging. Scramble cell surface markers, and you risk shifting their identity or killing off a chunk of your precious culture. Academic labs and industry groups both report trouble with harsher enzymes like trypsin, especially after repeated passages.
Acutase promises a softer touch. Data posted by suppliers highlight its performance compared to traditional trypsin: higher post-detachment viability, colonies that keep their shape, and surface markers mostly intact. The key is that the enzyme blend leaves fewer scars.
Despite the positive spin, not every batch of Acutase can be counted on blindly. Stem cell researchers swap stories of unexpected differentiation or sudden cell death after passaging. Usually, this tracks back to either enzyme concentration, exposure time, or batch variability. Overshooting the timing or leaving cells in contact with Acutase for too long can threaten their identity.
Some biologists raise concerns about residual enzymatic activity. Failing to fully rinse Acutase from cells sometimes leaves enough activity to keep breaking down proteins as cultures recover. This threatens the careful balance controlling stemness or pushes cells toward unwanted lineages.
Peer-reviewed journals weigh in with results from direct comparisons. A 2021 paper from Cell Reports Methods put Acutase, TrypLE, and trypsin through their paces using human pluripotent stem cells. Short, carefully timed Acutase treatments led to the best survival and kept stem cell markers high. Longer incubations, even with Acutase, slashed viability and triggered differentiation.
The International Society for Stem Cell Research recommends enzyme treatments under 10 minutes for human embryonic and iPSC lines. Several studies testing Acutase support these guidelines, showing healthy recovery and successful colony formation with brief exposure.
For researchers keeping stem cells or sensitive primary cells healthy, every variable counts. Don’t skip titrating the enzyme for your own workflow. Batch-to-batch shifts often crop up between bottles and suppliers. Always test on a small culture before scaling up. Set timers, work cold, and rinse early to protect cells from over-digestion.
Checking for hidden changes matters as much as watching morphology. Antibody staining for pluripotency markers like Oct4 and SSEA4 after passaging gives clues if the enzyme’s been too rough. Tracking proliferation after each passage picks up slow toxicity. If healthy colonies slip or markers drop, reduce contact time and test another lot.
Suppliers with ISO-certified manufacturing and detailed endotoxin documentation earn trust. Labs should track lot numbers, COAs, and any deviations from normal passage behavior. Regulators and funding agencies expect these records, especially in clinical or translational projects where minor changes have outsized effects.
Acutase gives a gentler alternative to traditional dissociation enzymes, proven in many settings. Safe use still hangs on careful technique and constant feedback from cultures themselves.
Acutase pops up in tissue culture rooms everywhere, promising gentler cell detachment than old-school trypsin. If you’ve handled stem cells or sensitive cell lines, you know how a few extra passages with harsh enzymes kill yield and slow projects. That’s where Acutase proves its worth—for delicate detachment that doesn’t strip surface proteins from your cells. Protecting this tool means paying attention to how it's stored and handled day by day.
Walk into most labs, and you’ll find Acutase in the fridge, never the benchtop. Refrigeration really matters. Acutase works best when held at 2–8°C. The manufacturers lay that out clearly, and in my own work, a bottle left out for a few hours quickly lost its punch. A chilly environment helps protect the delicate enzymes inside.
I remember one early morning, pulling a batch from the -20°C freezer after a delivery. While freezing offers some flexibility, repeated temperature cycling causes problems over time. Most suppliers warn against it. After thawing frozen Acutase, keep it in the fridge and avoid re-freezing. This habit spares your cells from inconsistent detachment rates and wasted days.
Manufacturers publish a 12-month shelf life for Acutase stored at 2–8°C. That’s the maximum range. Out in the real world, bottles run out faster, but if storage gets sloppy—like leaving it out overnight by accident—activity nosedives faster than labels predict.
For scientists aiming for reproducibility, that “12 months” only applies if storage stays tight from start to finish. I’ve worked in busy shared labs and seen students shaking up old, nearly-empty bottles and wondering why yields drop. Tracking the open date and sticking a clear expiration sticker helps everyone avoid mysteries at the microscope.
Cells respond quickly to enzymatic changes. If Acutase loses strength, you need longer incubations and tougher scrapes. Surface proteins become collateral damage, and experiments lose reliability. A faltering bottle blurs every endpoint—whether it’s passage, staining, or flow cytometry.
Healthy cell cultures build reliable science. I’ve seen first-hand how a simple slip—like using Acutase that’s been frozen and thawed twice, or gone cloudy from age—compromises weeks of work. You avoid those risks through careful tracking, using small aliquots, and following good cold-chain discipline.
Some labs use single-use aliquots instead of big working bottles. Prepping individual 1–5 mL tubes in advance means every thawed vial stays potent and uncontaminated. Inventory checklists and routine bottle checks keep the supply fresh. It’s a habit worth teaching to new arrivals.
Relying on color changes or cloudy appearance to judge viability isn’t enough. Running a quick performance test on new and old batches alongside each other clears up any doubts. It’s a lot easier to replace a bottle than to recover from bad passages.
If you depend on Acutase, treat it with the same respect as your most crucial reagents. Keeping it cold, tracking open dates, avoiding repeat freeze-thaw cycles, and using small aliquots mean you protect every cell—and every experiment. Storage isn’t just a routine step; it’s a difference-maker for reproducible results.
Over the years, lab folks like me have searched for tools that handle cells as gently as possible. Acutase steps into this role for good reason. This enzyme solution makes separating cells easy, with less stress than a lot of older methods. I’ve seen cell cultures that get cranky or stop growing after harsh enzymatic or mechanical cleanup. Acutase offers a mild answer, protecting surface proteins and keeping the cells healthier.
Anyone doing flow cytometry knows: clumped cells ruin results. Getting single-cell suspensions isn’t just a technicality — it’s the basis for clean data. Acutase helps achieve that single-cell state. It works well on many standard cell types, including adherent mammalian cells, making it a solid pick for common culture lines.
Cell surface markers matter in immunophenotyping, stem cell work, and sorting. Some enzymes chop off these markers, making downstream analysis tricky or unreliable. Acutase preserves antigens better than trypsin. I recall one experiment where antibodies targeting CD44 and CD133 struggled after trypsin but gave clear results after Acutase treatment.
Researchers have compared Acutase to trypsin and collagenase in peer-reviewed studies. In stem cell dissociation, for example, Acutase showed almost no reduction in surface protein detection. Neuronal cultures, which don’t handle rough treatment well, often stay healthier after Acutase digestion. Cell viability tends to run higher, and more cells survive freezing and thawing.
Downstream, I see more reliable counts and cleaner gating during sorting. Single-cell suspensions last longer before aggregating. For anyone working with finite or precious cell batches, getting more reliable results from less material really matters.
No dissociation reagent covers all bases. Some cell types, like primary tissues with dense ECM, resist Acutase and call for tougher solutions or mechanical help. If your sample includes cells fused into tight networks, you may not get perfect results on the first round. But for most passaged lab lines, Acutase strikes a balance between effective dissociation and cell health.
My own advice: check your target proteins. Prioritize experiments that compare Acutase with alternatives for your critical markers. Some subtle changes can crop up, depending on incubation time or cell density. Staying vigilant about controls during flow cytometry makes interpretation stronger.
Acutase shaves minutes off protocol time versus lengthy collagenase incubations. It runs at room temperature or 37°C, with short exposure lowering stress risk. Once you’ve got the cells in suspension, gentle pipetting and rapid transfer go far in avoiding cell loss. Acutase is animal origin-free, helping groups who want to steer clear of animal products for ethical or regulatory reasons.
Switching reagents always brings a learning curve. Careful titration, attention to timing, and running side-by-side comparisons set up robust future runs. The less time spent troubleshooting, the more time there is to focus on questions that move science forward.
| Names | |
| Preferred IUPAC name | Trypsin, serine (pig pancreas)-like (EC 3.4.21.4) |
| Other names |
Cell Dissociation Reagent Enzyme-Free Cell Dissociation Solution Cell Detachment Solution |
| Pronunciation | /əˈkjuːteɪs/ |
| Identifiers | |
| CAS Number | 113980-37-9 |
| 3D model (JSmol) | Sorry, I couldn't find a '3D model (JSmol)' string for the product 'Acutase'. |
| Beilstein Reference | 3751772 |
| ChEBI | CHEBI:46805 |
| ChEMBL | CHEMBL3989629 |
| ChemSpider | 50922974 |
| DrugBank | DB11113 |
| ECHA InfoCard | ECHA InfoCard: 03-2119954802-46-0000 |
| EC Number | 3.4.24.31 |
| Gmelin Reference | 1431503 |
| KEGG | ko04626 |
| MeSH | cell culture techniques |
| UNII | D7310J5V9Z |
| UN number | UN3316 |
| CompTox Dashboard (EPA) | DTXSID7067434 |
| Properties | |
| Chemical formula | C32H48O21 |
| Molar mass | 32 kDa |
| Appearance | Clear, colorless, odorless liquid |
| Odor | Odorless |
| Density | 0.982 g/mL |
| Solubility in water | Soluble in water |
| log P | -0.14 |
| Acidity (pKa) | 7.2 |
| Basicity (pKb) | 7.1 |
| Refractive index (nD) | 1.004 to 1.006 |
| Viscosity | Low viscosity |
| Dipole moment | 3.15 D |
| Pharmacology | |
| ATC code | V03IX26 |
| Hazards | |
| Main hazards | Causes skin and serious eye irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| Precautionary statements | Precautionary statements: P261, P280, P305+P351+P338, P304+P340, P312 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 0, Instability: 0, Special: - |
| LD50 (median dose) | > LD50 (median dose): > 5,000 mg/kg (oral, rat) |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10x |
| Related compounds | |
| Related compounds |
Trypsin Collagenase Dispase Papain Accutase |
